Login to Your Account

Financings Roundup

Friday, April 5, 2013
• Trimel Pharmaceuticals Corp., of Toronto, amended its preliminary short form prospectus with details related to changes to a previously announced proposed marketed offering of stock units consisting of one share of common stock and a warrant to purchase one half share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription